Irene Andrulis
Affiliations: | Molecular and Medical Genetics | University of Toronto, Toronto, ON, Canada |
Area:
Cell Biology, Molecular Biology, OncologyGoogle:
"Irene Andrulis"Children
Sign in to add trainee| Susan J. Done | grad student | 2000 | University of Toronto |
| Winnie W. Lo | grad student | 2012 | University of Toronto |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yiangou K, Mavaddat N, Dennis J, et al. (2024) Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction. Medrxiv : the Preprint Server For Health Sciences |
| Wichert K, Hoppe R, Ickstadt K, et al. (2023) Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer. European Journal of Epidemiology. 38: 1053-1068 |
| Middha P, Wang X, Behrens S, et al. (2023) A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry. Breast Cancer Research : Bcr. 25: 93 |
| Levi H, Carmi S, Rosset S, et al. (2023) Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. Journal of Medical Genetics |
| Figlioli G, Billaud A, Wang Q, et al. (2023) Spectrum and Frequency of Germline Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases. Cancers. 15 |
| Morra A, Schreurs MAC, Andrulis IL, et al. (2023) Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Medicine |
| Kast K, John EM, Hopper JL, et al. (2023) Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium. Breast Cancer Research : Bcr. 25: 72 |
| Muranen TA, Morra A, Khan S, et al. (2023) PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants. Npj Breast Cancer. 9: 37 |
| Morra A, Mavaddat N, Muranen TA, et al. (2023) The impact of coding germline variants on contralateral breast cancer risk and survival. American Journal of Human Genetics |
| Figlioli G, Billaud A, Ahearn TU, et al. (2023) FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. European Journal of Human Genetics : Ejhg |